Clinical Trial Update: 18F-DCFBC PET/CT in Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating 18F-DCFBC PET/CT for prostate cancer has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFBC (PSMA-targeted radiolabeled PET tracer using Fluorine-18)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms, Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-04-23